14 of the 19 patients who received a high dose of flecainide ( median daily dose 480 mg ) , demonstrated a 90 % or greater reduction in premature ventricular complexes , and ventricular tachycardia did not recur during treatment in 7 out of 9 patients .
C0016229
flecainide
C0042514
ventricular